The largest database of trusted experimental protocols

Ilab ultrasound imaging system

Manufactured by Boston Scientific
Sourced in United States

The ILAB™ Ultrasound Imaging System is a medical device designed for diagnostic imaging. It utilizes ultrasound technology to capture real-time visual representations of internal body structures. The system provides imaging capabilities to support clinical decision-making and patient care.

Automatically generated - may contain errors

Lab products found in correlation

5 protocols using ilab ultrasound imaging system

1

Integrating IVUS and Orthogonal AX Films for 3D Vessel Reconstruction

Check if the same lab product or an alternative is used in the 5 most similar protocols
IVUS images were acquired with the AtlantisTM SR Pro Imaging Catheter 40 MHz ECG-triggered and connected to an iLabTM Ultrasound Imaging System (Boston Scientific Corporation, Natick, MA, USA). The acquisition was performed with a frame rate of 30FPS and with constant velocity pullback at 0.5mm/s. IVUS images were gated as proposed in34 (link) to retrieve the diastolic cardiac phase. Additionally, two orthogonal (along the cranial-caudal plane) AX films were acquired, also ECG-triggered, spanning 8 heartbeats. A specialist selected the images from the AX films at the full exhalation end-diastolic phase. The integration of the AX images and the IVUS dataset enabled a consistent time-coherent reconstruction of the vessel in 3D space. Then, the lumen area was manually segmented by a specialist using cubic splines. The transducer path was retrieved using both AX images through a biplane snakes method35 . The recovered transducer path served to place the segmented luminal areas consistently with the acquisition time and the pullback velocity. Finally, the segmentation of side branches in the IVUS dataset was also manually performed. At a final stage, all contours were rotated around the axis described by the transducer path in order to minimize the mismatch between the projected luminal area from IVUS and the contrast observed in the AX film36 (link).
+ Open protocol
+ Expand
2

IVUS Assessment of Stent Expansion and Neointimal Formation

Check if the same lab product or an alternative is used in the 5 most similar protocols
IVUS was conducted as described previously (Cui et al., 2017 (link)). We used a 40-MHz 2.9 Fr sheath-based catheter (Atlantis, SR Pro, Boston Scientific) and IVUS (iLABTM Ultrasound Imaging System, Boston Scientific, Natick, MA, United States). The IVUS catheter was positioned 10 mm distal to the stent, and imaging was subsequently performed back to a point 10 mm proximal to the treated section using an automated transducer pullback at 0.5 mm/s. The scaffold area, minimal lumen area, intrascaffold neointimal area, and vessel area (area in the vessel’s EEL) were measured. The stent expansion index and percentage of lumen area stenosis were calculated according to the following formulas: stent expansion index = ([actual lumen area/ideal lumen area] × 100) and percentage of lumen area stenosis = ([mean lumen intrascaffold area ˗ the lumen area]/mean lumen intrascaffold area × 100).
+ Open protocol
+ Expand
3

Intravascular Ultrasound Examination of Culprit Lesions

Check if the same lab product or an alternative is used in the 5 most similar protocols
All patients were performed with coronary angiography by standard Judkins technique. IVUS examination was performed using an IVUS system (iLAB™ Ultrasound Imaging System, Boston Scientific, USA) and a 40 MHz intravascular catheter (OptiCross™, Boston Scientific, USA) before any intervention. The IVUS catheter was advanced into the culprit vessel more than 10 mm beyond the culprit lesion and withdrawn at a pullback speed of 0.5 mm/s automatically. In this study, a culprit lesion was defined as the lesion related to the clinical event, as identified by both coronary angiography and electrocardiogram findings. A ruptured plaque was defined as the plaque contained a cavity that communicated with the lumen with an overlying residual fibrous cap fragment. A fragmented and loosely adherent plaque without a distinct cavity and without a fibrous cap fragment was not considered as a plaque rupture [14 (link)]. IVUS quantitative analysis was performed by two independent experienced interventional cardiologists who were blinded to the patients’ clinical information according to the criteria of the American College of Cardiology Clinical Expert Consensus Document on IVUS.
+ Open protocol
+ Expand
4

Intravascular Ultrasound Imaging of Coronary Lesions

Check if the same lab product or an alternative is used in the 5 most similar protocols
After conventional coronary angiography, IVUS was performed at the baseline timepoint and repeated immediately after stent implantations in all cases. The IVUS examinations were performed using a Boston Scientific image processor iLab Ultrasound Imaging System. Briefly, the IVUS catheter was carefully advanced distal to the culprit lesion under fluoroscopic guidance, and was then withdrawn automatically at 0.5 mm/s to perform the imaging sequence, which started 20 mm distal to the lesion and ended at the aorto-ostial junction. For those patients with severely narrow lesions in which IVUS could not access the distal segment even after pre-dilatation, the minimum lumen cross-sectional area (CSA) was estimated as the lumen CSA of the arrival section.
+ Open protocol
+ Expand
5

Coronary Angiography and IVUS Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
The CAG procedures were performed according to generally accepted guidelines and routines [27 (link), 28 (link)]. The radial artery was the preferred access approach. Lesions were imaged in at least two different projections, preferably at 90°. A lesion with a reduced luminal diameter of at least 50% was considered significant. All procedures were performed by two experienced interventional cardiologists, with sub-senior title or higher. Both the cardiologists decided together whether or not an IVUS procedure was needed after CAG. After intracoronary administration of 200 μg of nitroglycerin, pre-intervention IVUS imaging of all the coronaries was performed using a commercially available IVUS system and catheter (iLab™ Ultrasound Imaging System, Boston Scientific Corp. Natic, MA, USA; Opticross™ 3.0 F intracoronary ultrasound catheter, Boston Scientific). The IVUS catheter was placed at least 10 mm distal to the lesion and then moved backward automatically at a speed of 0.5 mm/s until it reached the coronary ostium.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!